Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer
S.M. Jamshedur Rahman, … , Jamey D. Young, Pierre P. Massion
S.M. Jamshedur Rahman, … , Jamey D. Young, Pierre P. Massion
Published November 17, 2016
Citation Information: JCI Insight. 2016;1(19):e88814. https://doi.org/10.1172/jci.insight.88814.
View: Text | PDF
Research Article Metabolism Oncology

The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer

  • Text
  • PDF
Abstract

The molecular determinants of lung cancer risk remain largely unknown. Airway epithelial cells are prone to assault by risk factors and are considered to be the primary cell type involved in the field of cancerization. To investigate risk-associated changes in the bronchial epithelium proteome that may offer new insights into the molecular pathogenesis of lung cancer, proteins were identified in the airway epithelial cells of bronchial brushing specimens from risk-stratified individuals by shotgun proteomics. Differential expression of selected proteins was validated by parallel reaction monitoring mass spectrometry in an independent set of individual bronchial brushings. We identified 2,869 proteins, of which 312 proteins demonstrated a trend in expression. Pathway analysis revealed enrichment of carbohydrate metabolic enzymes in high-risk individuals. Glucose consumption and lactate production were increased in human bronchial epithelial BEAS2B cells treated with cigarette smoke condensate for 7 months. Increased lipid biosynthetic capacity and net reductive carboxylation were revealed by metabolic flux analyses of [U-13C5] glutamine in this in vitro model, suggesting profound metabolic reprogramming in the airway epithelium of high-risk individuals. These results provide a rationale for the development of potentially new chemopreventive strategies and selection of patients for surveillance programs.

Authors

S.M. Jamshedur Rahman, Xiangming Ji, Lisa J. Zimmerman, Ming Li, Bradford K. Harris, Megan D. Hoeksema, Irina A. Trenary, Yong Zou, Jun Qian, Robbert J.C. Slebos, Jennifer Beane, Avrum Spira, Yu Shyr, Rosana Eisenberg, Daniel C. Liebler, Jamey D. Young, Pierre P. Massion

×

Figure 3

Validation of protein expression by quantitative measurements of carbohydrate metabolic enzyme expression by PRM MS in an independent set of individual bronchial brushings.

Options: View larger image (or click on image) Download as PowerPoint
Validation of protein expression by quantitative measurements of carbohy...
Each sample was analyzed on a Q-Exactive mass spectrometer using an acquisition method that combined a full-scan SIM event followed by 14 PRM scans. Two replicates of each specimen from low-risk individuals (n = 10) were compared with those of the high-risk individuals (n = 10). Likelihood ratio test based on mixed effect model. Top row: enzymes involved in glycogenolysis and galactose supply that feeds glucose into glycolysis and the pentose phosphate pathway. Middle row: glycolytic pathway enzymes. Bottom row: TCA cycle enzymes.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts